M-DIENOGEST 2 MG
DIENOGEST : 2 MG · DIN 02543613 · MANTRA PHARMA INC
Health Canada status: MARKETED
What is M-DIENOGEST?
M-DIENOGEST 2 MG contains DIENOGEST : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02543613, held by MANTRA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Apr-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is M-DIENOGEST used for?
M-DIENOGEST (dienogest) is indicated for the management of pelvic pain associated with endometriosis. Efficacy of dienogest has not been tested beyond 15 months.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02543613 |
|---|---|
| Brand name | M-DIENOGEST |
| Generic / active ingredient | DIENOGEST : 2 MG |
| Manufacturer | MANTRA PHARMA INC |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G03DB08 DIENOGEST |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Apr-2024 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code G03DB08 DIENOGEST. 5 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ASPEN-DIENOGEST | 2 MG | TABLET | ASPEN PHARMACARE CANADA INC. | MARKETED | DIN 02493055 |
| JAMP DIENOGEST | 2 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02498189 |
| MAR-DIENOGEST | 2 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02551683 |
| VISANNE | 2 MG | TABLET | BAYER INC | MARKETED | DIN 02374900 |
Who else supplies DIENOGEST worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIENOGEST appears in 718 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.